Affiliation 1 was incorrectly listed as ‘Experimental Oncology Unit, Department of Microbiology, Immunology and Parasitology, University of São Paulo, São Paulo, Brazil’ in the original version of the Article. The correct affiliation is listed below:
Experimental Oncology Unit, Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, Brazil.
In Addition, E.G. Rodrigues was incorrectly listed as being affiliated with ‘Laboratory of Cancer Immunobiology, University of São Paulo, São Paulo, Brazil’.
The correct affiliation is listed below:
Laboratory of Cancer Immunobiology, Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, Brazil.
These errors have now been corrected in the HTML and PDF versions of this Article.
Additional information
The online version of the original article can be found at 10.1038/srep40585
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Berzaghi, R., Maia, V., Pereira, F. et al. Erratum: SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression. Sci Rep 7, 42827 (2017). https://doi.org/10.1038/srep42827
Published:
DOI: https://doi.org/10.1038/srep42827
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
